Choosing preclinical study models of diabetic retinopathy: key problems for consideration - Wikidata - wikimedia - TriplyDB

Choosing preclinical study models of diabetic retinopathy: key problems for consideration

Choosing preclinical study models of diabetic retinopathy: key problems for consideration

http://www.wikidata.org/entity/Q34564352

about

The mechanism of CCN1-enhanced retinal neovascularization in oxygen-induced retinopathy through PI3K/Akt-VEGF signaling pathway.Matrix metalloproteinase-9 and vascular endothelial growth factor expression change in experimental retinal neovascularization.Effects of Diets with Different Proportions of Protein/Carbohydrate on Retinal Manifestations in db Mice.Remodeling of Retinal Architecture in Diabetic Retinopathy: Disruption of Ocular Physiology and Visual Functions by Inflammatory Gene Products and Pyroptosis

P2860

Q35586224-4691E3B9-BE29-4E9C-AD5F-C6C37D75B5D7 Q37026766-1D0BCF3C-0934-46DA-B3D4-7FCC45B9E2ED Q55270087-A29E395D-1B5D-4938-84A3-9033ED64767A Q58762933-621875C2-AF94-41F1-B0FB-C1E443B63410

P2860

Choosing preclinical study models of diabetic retinopathy: key problems for consideration

http://www.wikidata.org/entity/Q34564352

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Choosing preclinical study models of diabetic retinopathy: key problems for consideration

@ast

Choosing preclinical study models of diabetic retinopathy: key problems for consideration

@en

Choosing preclinical study models of diabetic retinopathy: key problems for consideration

@nl

type

label

Choosing preclinical study models of diabetic retinopathy: key problems for consideration

@ast

Choosing preclinical study models of diabetic retinopathy: key problems for consideration

@en

Choosing preclinical study models of diabetic retinopathy: key problems for consideration

@nl

prefLabel

Choosing preclinical study models of diabetic retinopathy: key problems for consideration

@ast

Choosing preclinical study models of diabetic retinopathy: key problems for consideration

@en

Choosing preclinical study models of diabetic retinopathy: key problems for consideration

@nl

P1433

Q34564352-AA755C94-A459-4B3B-A589-1716AD0F801D

P1476

Q34564352-10B57DEC-A629-48A0-839C-7481DEBCF4EA

P2093

Q34564352-934A517F-B1CD-4D76-8DDD-8835679087F4

Q34564352-96400BE5-038B-41FB-BB6F-3FFC2304D5F1

Q34564352-D5627574-87B6-4BC4-B6D6-C4168D46A6A4

Q34564352-FE0699DD-5F71-4EA7-A5CE-9F9A4196CF5E

P275

Q34564352-FB9BB1FD-63D1-4FB3-9772-FF210FC83DDC

P2860

Q34564352-04C64633-A526-4184-8833-DB1B6D056512

Q34564352-05A11390-FE4C-482A-AEDD-E057FCAC16EA

Q34564352-06705A3D-6069-49F9-940F-40C2AF9437A6

Q34564352-06BABE09-8CF6-48E1-8434-8A1129664D95

Q34564352-0AA4AE28-5CB6-4E08-9E1D-C68756881A9B

Q34564352-0BB3E3AD-A693-40E7-A1B1-4DBFC431246A

Q34564352-0BF92BC0-60BD-45A1-9C9A-7C43A38FFC95

Q34564352-0E26126D-7009-4BF2-8DFF-91F64A3667AD

Q34564352-0E947146-DF08-4773-9512-D59D1B20CD06

Q34564352-14FFC125-657D-4FAA-98C9-42D893279703

P304

Q34564352-BC441F85-F803-496D-85B5-8FF6F712259E

P31

Q34564352-69F1CA45-4BE5-464D-8BF5-29B10C93A4A4

Q34564352-9B46F0F3-3268-44A1-8435-136715E1901C

P356

Q34564352-5F1260A8-C4AF-4D53-86ED-1EBEB9E8E334

P407

Q34564352-186DBED9-CC8F-407B-B35D-75C41B6D0704

P478

Q34564352-0F5EFEC5-D398-4DC0-B2E7-FB29C01798E2

P50

Q34564352-9381E0C2-6AF3-4A57-A715-EF092DE6AFD2

P5008

Q34564352-8C5107DB-5AC3-420D-BC47-BB7448EF2644

P577

Q34564352-7173A2DE-AD4F-4EB0-B2DC-0135919898D5

P698

Q34564352-3CB8988B-6AD1-4A2F-A535-9B25C4C40B25

P921

Q34564352-46E67E77-3456-4B79-B18D-D02DDEFA5FCC

Q34564352-67361DD1-BAC4-44CC-8C1B-6F0468E931A0

P932

Q34564352-B350F370-D374-431E-8B9D-19F39ACE5610

P356

P1433

Drug Design, Development and Therapy

P1476

Choosing preclinical study models of diabetic retinopathy: key problems for consideration

@en

P2093

Jing-Xiang Zhong

http://www.w3.org/2001/XMLSchema#string

Ti-Fei Yuan

http://www.w3.org/2001/XMLSchema#string

Xue-Song Mi

http://www.w3.org/2001/XMLSchema#string

Yong Ding

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Role of endothelial cell and pericyte dysfunction in diabetic retinopathy: review of techniques in rodent models

Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema

Zebrafish--on the move towards ophthalmological research

Retinal vascular changes and systemic diseases: corrosion cast demonstration.

Retinal changes in Otsuka long-evans Tokushima Fatty rats (spontaneously diabetic rat)--possibility of a new experimental model for diabetic retinopathy.

Microglial changes occur without neural cell death in diabetic retinopathy.

Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.

Longitudinal in vivo imaging of retinal gliosis in a diabetic mouse model.

Reduced ocular blood flow as an early indicator of diabetic retinopathy in a mouse model of diabetes.

Functional foods-based diet as a novel dietary approach for management of type 2 diabetes and its complications: A review

P304

2311-2319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S72797

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2014-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25429204

http://www.w3.org/2001/XMLSchema#string

P921

diabetic retinopathy

biomedical investigative technique

P932

4242133

http://www.w3.org/2001/XMLSchema#string